Form 4: Pfizer Director Scott Gottlieb Reports Stock Purchase
SEC Form 4 Filing
Director Scott Gottlieb reported purchasing 1,000 shares of Pfizer stock at $28.24 on October 30, 2024.
Summary
- On October 30, 2024, Scott Gottlieb, a director of Pfizer Inc., purchased 1,000 shares of Pfizer's common stock.
- The purchase price was $28.24 per share.
- Following the transaction, Gottlieb directly owns 10,000 shares of Pfizer stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction report. The purchase itself is slightly positive, indicating confidence, but it's a small amount.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities.
Stakeholder Impact
- The stock purchase by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 10/30/2024 | Date of stock purchase transaction |
| 10/31/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.